Literature DB >> 24339834

Meta-analysis of safety for low event-rate binomial trials.

Jonathan J Shuster1, Jennifer D Guo2, Jay S Skyler3.   

Abstract

This article focuses on meta-analysis of low event-rate binomial trials. We introduce two forms of random effects: (1) 'studies at random' (SR), where we assume no more than independence between studies; and (2) 'effects at random' (ER), which forces the effect size distribution to be independent of the study design. On the basis of the summary estimates of proportions, we present both unweighted and study-size weighted methods, which, under SR, target different population parameters. We demonstrate mechanistically that the popular DerSimonian-Laird (DL) method, as DL actually warned in their paper, should never be used in this setting. We conducted a survey of the major cardiovascular literature on low event-rate studies and found that DL using odds ratios or relative risks to be the clear method of choice. We looked at two high profile examples from diabetes and cancer, respectively, where the choice of weighted versus unweighted methods makes a large difference. A large simulation study supports the accuracy of the coverage of our approximate confidence intervals. We recommend that before looking at their data, users should prespecify which target parameter they intend to estimate (weighted vs. unweighted) but estimate the other as a secondary analysis.
Copyright © 2012 John Wiley & Sons, Ltd. Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Keywords:  meta-analysis; odds ratio; random effects; relative risk

Year:  2012        PMID: 24339834      PMCID: PMC3856441          DOI: 10.1002/jrsm.1039

Source DB:  PubMed          Journal:  Res Synth Methods        ISSN: 1759-2879            Impact factor:   5.273


  41 in total

1.  What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.

Authors:  Michael J Sweeting; Alexander J Sutton; Paul C Lambert
Journal:  Stat Med       Date:  2004-05-15       Impact factor: 2.373

2.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 3.  Association between hormone replacement therapy and subsequent stroke: a meta-analysis.

Authors:  Philip M W Bath; Laura J Gray
Journal:  BMJ       Date:  2005-01-07

4.  Fixed vs random effects meta-analysis in rare event studies: the rosiglitazone link with myocardial infarction and cardiac death.

Authors:  Jonathan J Shuster; Lynn S Jones; Daniel A Salmon
Journal:  Stat Med       Date:  2007-10-30       Impact factor: 2.373

5.  Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.

Authors:  Jeffrey S Berger; Mori J Krantz; John M Kittelson; William R Hiatt
Journal:  JAMA       Date:  2009-05-13       Impact factor: 56.272

6.  Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

Authors:  Philip D Home; Stuart J Pocock; Henning Beck-Nielsen; Paula S Curtis; Ramon Gomis; Markolf Hanefeld; Nigel P Jones; Michel Komajda; John J V McMurray
Journal:  Lancet       Date:  2009-06-06       Impact factor: 79.321

Review 7.  Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials.

Authors:  Jonathan P Piccini; Jeffrey S Berger; Christopher M O'Connor
Journal:  Eur Heart J       Date:  2009-03-31       Impact factor: 29.983

8.  Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis.

Authors:  Leanne Bellamy; Juan-Pablo Casas; Aroon D Hingorani; David Williams
Journal:  Lancet       Date:  2009-05-23       Impact factor: 79.321

9.  Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.

Authors:  Paolo Verdecchia; Fabio Angeli; Claudio Cavallini; Roberto Gattobigio; Giorgio Gentile; Jan A Staessen; Gianpaolo Reboldi
Journal:  Eur Heart J       Date:  2009-01-23       Impact factor: 29.983

10.  A basic introduction to fixed-effect and random-effects models for meta-analysis.

Authors:  Michael Borenstein; Larry V Hedges; Julian P T Higgins; Hannah R Rothstein
Journal:  Res Synth Methods       Date:  2010-11-21       Impact factor: 5.273

View more
  13 in total

Review 1.  Repetitive Transcranial Magnetic Stimulation (rTMS) Therapy in Parkinson Disease: A Meta-Analysis.

Authors:  Aparna Wagle Shukla; Jonathan J Shuster; Jae Woo Chung; David E Vaillancourt; Carolynn Patten; Jill Ostrem; Michael S Okun
Journal:  PM R       Date:  2015-08-24       Impact factor: 2.298

2.  Rejoinder to the discussion of "a Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons," by S. Dias and A. E. Ades.

Authors:  Hwanhee Hong; Haitao Chu; Jing Zhang; Bradley P Carlin
Journal:  Res Synth Methods       Date:  2015-10-13       Impact factor: 5.273

3.  Verification of association of elevated serum IDO enzyme activity with acute rejection and low CD4-ATP levels with infection.

Authors:  Vikas R Dharnidharka; Eihab Al Khasawneh; Sushil Gupta; Jonathan J Shuster; Douglas W Theriaque; Amir H Shahlaee; Timothy J Garrett
Journal:  Transplantation       Date:  2013-09       Impact factor: 4.939

4.  Meta-analysis of rare adverse events in randomized clinical trials: Bayesian and frequentist methods.

Authors:  Hwanhee Hong; Chenguang Wang; Gary L Rosner
Journal:  Clin Trials       Date:  2020-12-01       Impact factor: 2.486

5.  Bayesian hierarchical models for network meta-analysis incorporating nonignorable missingness.

Authors:  Jing Zhang; Haitao Chu; Hwanhee Hong; Beth A Virnig; Bradley P Carlin
Journal:  Stat Methods Med Res       Date:  2015-07-28       Impact factor: 3.021

6.  A Pocock approach to sequential meta-analysis of clinical trials.

Authors:  Jonathan J Shuster; Josef Neu
Journal:  Res Synth Methods       Date:  2013-09       Impact factor: 5.273

7.  Sensitivity to Excluding Treatments in Network Meta-analysis.

Authors:  Lifeng Lin; Haitao Chu; James S Hodges
Journal:  Epidemiology       Date:  2016-07       Impact factor: 4.822

8.  Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology.

Authors:  Steven R Messé; Gary S Gronseth; David M Kent; Jorge R Kizer; Shunichi Homma; Lee Rosterman; John D Carroll; Koto Ishida; Navdeep Sangha; Scott E Kasner
Journal:  Neurology       Date:  2020-04-29       Impact factor: 11.800

Review 9.  Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis.

Authors:  Stephen E Borst; Jonathan J Shuster; Baiming Zou; Fan Ye; Huanguang Jia; Anita Wokhlu; Joshua F Yarrow
Journal:  BMC Med       Date:  2014-11-27       Impact factor: 8.775

10.  Low-event-rate meta-analyses of clinical trials: implementing good practices.

Authors:  Jonathan J Shuster; Michael A Walker
Journal:  Stat Med       Date:  2016-01-05       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.